Recurrent Miscarriage Profile II

Recurrent Miscarriage Panel II – Autoimmune & Antiphospholipid Syndrome Screening

The Recurrent Miscarriage Panel II is a specialized diagnostic test designed for women who have experienced multiple pregnancy losses due to autoimmune or blood clotting disorders. This panel focuses on antiphospholipid antibodies (APLA) and other immune markers associated with recurrent miscarriage, stillbirth, and pregnancy complications such as preeclampsia. Early detection of these conditions can help in managing risks and improving pregnancy outcomes.

Tests Included in the Package:

1. Lupus Anticoagulant (LA) – Screens for antibodies that increase the risk of abnormal blood clotting, a major cause of recurrent miscarriages.
2. Cardiolipin Antibody (IgG & IgM) – Detects autoantibodies against cardiolipin, which are associated with Antiphospholipid Syndrome (APS) and recurrent pregnancy loss.
3. Anti-Phospholipid Antibodies Screen (IgG & IgM) – Identifies the presence of antiphospholipid antibodies that can interfere with normal placental function, increasing the risk of pregnancy complications.

Why Choose This Test?

• Essential for Women with Recurrent Pregnancy Loss – Helps diagnose autoimmune disorders linked to multiple miscarriages.
• Early Detection of Antiphospholipid Syndrome (APS) – APS is a leading cause of pregnancy loss and complications like stillbirth and preeclampsia.
• Accurate & Reliable Testing – Uses advanced laboratory methods to detect autoantibodies affecting pregnancy.
• Supports Personalized Treatment Plans – Early diagnosis allows for preventive measures such as anticoagulant therapy (aspirin, heparin) to reduce miscarriage risk.
• Safe & Non-Invasive – A simple blood test providing critical insights into immune-related pregnancy risks.

Who Should Take This Test?

• Women with a history of two or more consecutive miscarriages.
• Those diagnosed with autoimmune conditions such as lupus or rheumatoid arthritis.
• Women with a history of preeclampsia, stillbirth, or unexplained pregnancy complications.
• Individuals with a family history of clotting disorders or suspected Antiphospholipid Syndrome (APS).